BePharBel Manufacturing Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 109

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.56M

  • Investors
  • 12

BePharBel Manufacturing General Information

Description

Manufacturer of pharmaceutical and para-pharmaceutical products intended to provide efficient and reliable medicines at accessible prices. The company's products meet both stringent and regulated European standards and provide generic drugs, including tablets, oral liquids, and injectables, enabling patients to begin treatment more quickly and resulting in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 13 Rue du Luxembourg
  • 6180 Courcelles
  • Belgium
+32 071
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 13 Rue du Luxembourg
  • 6180 Courcelles
  • Belgium
+32 071

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BePharBel Manufacturing Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 06-Oct-2023 $2.56M Completed Generating Revenue
8. Later Stage VC 27-Jun-2019 Completed Generating Revenue
7. Debt - General 01-Mar-2019 Completed Generating Revenue
6. Early Stage VC 14-Jul-2015 Completed Generating Revenue
5. Early Stage VC 26-Jun-2014 Completed Generating Revenue
4. Debt - General 01-Feb-2014 Completed Generating Revenue
3. Debt - General 01-Feb-2014 Completed Generating Revenue
2. Early Stage VC 25-Jul-2013 $556K $1.01M Completed Generating Revenue
1. Early Stage VC 03-Oct-2012 $452K $452K Completed Startup
To view BePharBel Manufacturing’s complete valuation and funding history, request access »

BePharBel Manufacturing Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 18,940 $23.93 $23.93 1x $23.93 3.16%
Ordinary 23,340 $15.95 $15.95 1x $15.95 3.9%
To view BePharBel Manufacturing’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BePharBel Manufacturing Patents

BePharBel Manufacturing Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2944568-T3 Multilayer microparticles for the delivery of pharmaceutically active compounds in liquid dosage form Active 17-Jul-2015
AU-2016294734-A1 Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form Active 17-Jul-2015
AU-2016294734-B2 Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form Active 17-Jul-2015
CA-2992356-A1 Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form Active 17-Jul-2015
CA-2992356-C Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form Active 17-Jul-2015 A61K9/5073
To view BePharBel Manufacturing’s complete patent history, request access »

BePharBel Manufacturing Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BePharBel Manufacturing Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Carbon ( Belgium ) Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 12 investors. Get the full list »

BePharBel Manufacturing Acquisitions (1)

BePharBel Manufacturing’s most recent deal was a Merger/Acquisition with Erfa Pharm. The deal was made on 06-Mar-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Erfa Pharm 06-Mar-2014 Merger/Acquisition Other Healthcare Services
To view BePharBel Manufacturing’s complete acquisitions history, request access »

BePharBel Manufacturing FAQs

  • When was BePharBel Manufacturing founded?

    BePharBel Manufacturing was founded in 2012.

  • Where is BePharBel Manufacturing headquartered?

    BePharBel Manufacturing is headquartered in Courcelles, Belgium.

  • What is the size of BePharBel Manufacturing?

    BePharBel Manufacturing has 109 total employees.

  • What industry is BePharBel Manufacturing in?

    BePharBel Manufacturing’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is BePharBel Manufacturing a private or public company?

    BePharBel Manufacturing is a Private company.

  • What is the current valuation of BePharBel Manufacturing?

    The current valuation of BePharBel Manufacturing is .

  • What is BePharBel Manufacturing’s current revenue?

    The current revenue for BePharBel Manufacturing is .

  • How much funding has BePharBel Manufacturing raised over time?

    BePharBel Manufacturing has raised $25.3M.

  • Who are BePharBel Manufacturing’s investors?

    , , Carbon ( Belgium ), , and are 5 of 12 investors who have invested in BePharBel Manufacturing.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process